Sanofi SA ADR
SNY: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| &g | LOCK|^l@% | LOCK|g!#J>f |
Sanofi's New Leadership Faces Looming Patent Cliff
Business Strategy and Outlook
Sanofi's wide lineup of branded drugs and vaccines and robust pipeline creates strong cash flows and a narrow economic moat.
